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When bottromycin AZ was added to an in vitro protein synthesis ystem carried out by naturally occurring 
polysomes, it inhibited protein synthesis effectively. Examination of the 3 steps of peptide chain elongation 
revealed that the binding of aminoacyl-tRNA to the polyribosomes was inhibited by bottromycin AZ. In 
contrast, we concluded that the peptide bond formation and the translocation steps in this system were 
not inhibited by bottromycin AZ on the basis of the following observations: (1) The break-down of 
polysomes, which is dependent on EFG, puromycin and RR (ribosome releasing) factor, was insensitive 
to bottromycin AZ; (2) The puromycin dependent release of polypeptide from polysomes, with or without 
EFG, was not inhibited by bottromycin AZ. Thus bottromycin specifically interferes with proper 
functioning of the A sites of polysomes. This is consistent with the results obtained using the model system 
with synthetic polynucleotides. 
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1. INTRODUCTION 
Bottromycin AZ is produced by Streptomyces 
and is a specific inhibitor of bacterial protein syn- 
thesis [1,2]. It has been suggested that it is an in- 
hibitor of translocation [3] and of peptide bond 
formation [4]. In [5,6] we reported that bot- 
tromycin AZ interferes with the ribosomal A site 
(acceptor site) in the model system. This conclu- 
sion was derived from observations that bot- 
tromycin AZ releases oligopeptidyl-tRNAs and 
aminoacyl-tRNAs from the A site. Because of this 
releasing reaction, bottromycin A2 inhibited the 
binding of aminoacyl-tRNA to the A site [5]. It has 
also been reported that bottromycin AZ inhibits the 
puromycin reaction with ribosome-bound 
polylysyl- or N-acetyl-phenylalanyl-tRNA if 
puromycin concentration is relatively low. This ef- 
fect, however, was explained on the basis that bot- 
tromycin AZ interferes with the A site [2], thereby 
making it more difficult for puromycin to enter 
161. 
Abbreviations: EFG, elongation factor G; DTT, 
dithiothreitol; Tris, Tris-(hydroxymethyl) amino- 
methane; EFTu, elongation factor Tu 
One puzzling fact about bottromycin AZ has 
been its relative ineffectiveness on the puromycin 
reaction with nascent polypeptidyl-tRNA on 
polysomes [7]. In contrast, the antibiotic effective- 
ly inhibits phenylalanyl-puromycin or N-acetyl- 
phenylalanyl-puromycin formation in a 
polyuridylic acid (poly U)-dependent system [4,6]. 
To elucidate this puzzle and to extend our 
hypothesis that bottromycin A2 acts on the accep- 
tor site of ribosomes, we examined the effect of 
bottromycin A2 on polyribosomes. The drug failed 
to inhibit translocation or peptide bond formation 
in this system but lessened the binding of 
aminoacyl-tRNA to the polysomes. Our unified 
hypothesis that bottromycin A2 interferes with the 
A site of ribosomes appears to apply also to 
naturally occurring polysomes. 
2. MATERIALS AND METHODS 
The Escherichia co/i extract, ribosomes and 
polyribosomes were prepared as in [5,6,8,9]. The 
source of antibiotics was as in [5,10]. Bottromycin 
A2 was kindly provided by Dr N. Tanaka of Tokyo 
University. 
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2.1. Amino acid incorporation system with 
polysomes 
The reaction mixture (0.25 ml) for the assay of 
protein synthesis using intact polysomes contained 
20 mM Tris-HCl (pH 7.8), 1 mM DTT, 50 mM 
NH&l, 8 mM magnesium acetate, 0.2 mM GTP, 
7 mM phosphoenolpyruvate, 8.9pg of pyruvate 
kinase, 98.7 pg of S-150 [lo], 340 pg of a tRNA 
mixture (containing 1.6 x lo5 cpm of [‘4C]valyl-, 
[r4C]glycyl-, [14C]seryl-, [14C]alanyl tRNA), (other 
aminoacyl-tRNAs were prepared with “C-amino 
acids), and 2.2 AzeO nunits of polysomes. Where 
indicated, 10v4 M bottromycin Az was added. The 
mixture was incubated at 22”C, and the hot 
trichloroacetic acid-insoluble radioactivity was 
measured by the filter disc method [ 111. 
The mixture (0.35 ml) for protein synthesis us- 
ing puromycin-pretreated polysomes was essential- 
ly the same as above except hat it contained 6 mM 
magnesium acetate, 480 pg of soluble enzymes free 
of RR factor [14,15] in place of S-150, 
1.37 A260 nunit of puromycin-pretreated 
polysomes [lo] and 230 pg of a tRNA mixture con- 
taining 1.7 x 10’ cpm of [14C]valyl-, [14C]alanyl-, 
[r4C]seryl- and [‘4C]glycyl-tRNA (other 
aminoacyl-tRNAs were prepared with 12C-amino 
acids). Where indicated, 10e4 M bottromycin AZ 
was added and the reaction mixture was incubated 
for 10 min at 30°C. 
2.2. Binding of aminoacyl-tRNA to polysomes 
The formation of the EFTu aminoacyl- 
tRNA-GTP ternary complex was carried out as in 
[12]. The reaction mixture (0.35 ml) for the 
binding of 15 [14C]aminoacyl-tRNAs (made 
with uniformly 14C-labeled amino acid mixture 
from New England Nuclear) contained 200 ~1 
of puromycin-treated polysomes (11.5 
A260 nunits/ml) and 4.6 X lo4 cpm of 15 
[14C]aminoacyl-tRNA-EFTu-GTP ternary com- 
plexes. Where indicated, 10e4 M bottromycin AZ 
was added. After preincubation of polysomes with 
bottromycin A2 for 3 min at 37”C, the binding 
reaction was carried out for 5 min and 15 min at 
37°C. The reaction mixture (300 ~1) was then plac- 
ed on 4.8 ml of a sucrose gradient (15-30% in 
10 mM Tris-HCl (pH 7.4), 10 mM magnesium 
acetate, 50 mM NH4Cl and 6mM p- 
mercaptoethanol). The tubes were centrifuged for 
55 min at 38000 rev./min with an SW 50.1 rotor. 
54 
Fractions (4 drops each) were collected from the 
bottom of the tube and the ribosome-bound cold 
(4°C) and hot (95“C) trichloroacetic acid-insoluble 
radioactivities were measured by the filter disc 
method [l I]. The values of hot trichloroacetic 
acid-soluble radioactivities (cold trichloroacetic 
acid-insoluble radioactivities minus hot 
trichloroacetic acid-insoluble radioactivities) were 
regarded as bound [r4C]aminoacyl-tRNA. This 
value is sensitive to RNase. 
2.3. The assay of EFG-dependent puromycin 
reaction using polysomes with bound nascent 
polypeptides 
Polyribosomes containing nascent peptides 
labeled with 14C amino acids were prepared as 
follows: The reaction mixture (2 ml) contained 
1.7 ml polysomes (11.5 A260 nunits/ml) and 2.6 X 
lo8 cpm of 15 [14C]aminoacyl-tRNA-EFTu-GTP 
ternary complexes. The incubation was carried out 
for 15 min at 37”C, and labeled polysomes were 
isolated by sucrose density gradient centrifugation. 
The reaction mixture (0.35 ml) for the puromycin 
reaction with polysomes contained 3 10 ~1 
polysomes carrying the [14C]peptidyl-tRNA ob- 
tained above and 0.1 mM puromycin. Where in- 
dicated, 10m4 M bottromycin AZ, 4.7 pg EFG and 
0.1 mM GTP were added. The incubation was car- 
ried out for 3 min at 37°C. The mixture (300~1) 
was analyzed by sucrose gradient centrifugation as 
in section 2.2. Hot (95’C) trichloroacetic acid- 
insoluble radioactivity bound to the ribosomes was 
measured by the disc filter method [l 11. 
3. RESULTS 
3.1. Effect of bottromycin AZ on protein synthesis 
by naturally-occurring polysomes 
In fig. 1, naturally-occurring polysomes with 
nascent peptide chains were isolated and their pro- 
tein synthetic activity was measured. It is clear 
from fig.1 that bottromycin A2 has an inhibitory 
effect on protein synthesis by polyribosomes. 
However, it was noted that the inhibition was less 
at the beginning of the reaction. 
In [5] we reported that oligopeptidyl-tRNA was 
released by bottromycin AZ in the poly(U)- 
dependent polyphenylalanine synthesis system. In 
the polysomal system shown in fig.1, however, no 
appreciable release of peptidyl-tRNA took place 
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tor which releases ribosomes from mRNA 
[10,14,15] from the crude soluble extract [lo]. 
Taking advantage of such an RR-factor-free ex- 
tract, the effect of bottromycin A2 was studied on 
puromycin-treated polysomes. Over 99Vo inhibi- 
tion (from 7000 cpm to 42 cpm) was observed 
under conditions otherwise similar to those in 
fig. 1. The inhibition by bottromycin A2 was much 
stronger than in the case using untreated 
polysomes with bound nascent polypeptides 
(fig. 1). 
3.3. Lack of inhibitory effect of bottromycin A2 
on translocation or the peptidyl transferase 
reaction 
In table 1, polysomes isolated from growing E. 
coli were first incubated with a mixture of 
[‘4C]aminoacyl-tRNA-EFTu and GTP complexes 
so that the binding of aminoacyl-tRNA could take 
place at the A sites of polysomes. The peptidyl 
transferase present in the polysomes would then 
catalyze the peptide bond formation between the 
nascent polypeptide chain and the newly bound 
[‘4C]aminoacyl-tRNA. The radioactive polypep- 
tide chains thus made will react with puromycin if 
they are located at the D (donor) or P (peptidyl) 
site. On the other hand, the peptidyl-tRNA which 
was bound at the A (acceptor) site does not react 
with puromycin in the absence of EFG and GTP. 
The results in table 2 show that the puromycin 
INCUBATION TIME, (minutes) 
Fig. 1. Time course of protein synthesis by 
polyribosomes in the presence of bottromycin AZ. 
Experimental conditions are described in the text. 
Bottromycin was added 3 min prior to the addition of 
labeled aminoacyl-tRNA because we suspected that the 
antibiotic might have difficulty in binding to polysomes 
as erythromycin does [13]: (0) no addition; (0) 10e4 M 
bottromycin was added. 
from the polysomes under conditions where bot- 
tromycin A2 had a very strong inhibitory effect on 
protein synthesis (not shown). 
3.2. Effect of bottromycin A2 on puromycin- 
pretreated polyribosomes 
In [7] the puromycin reaction with 
polyribosomes was insensitive to bottromycin AZ. 
This observation, together with the relative inef- 
fectiveness of bottromycin A2 on initial protein 
synthesis by polyribosomes, suggests that the inef- 
fectiveness is due to the nascent peptidyl group 
which might cause steric hindrance between the 
ribosomes and bottromycin AZ. It is possible to 
study protein biosynthesis using polyribosomes 
with their nascent chains removed because one can 
specifically eliminate ribosome-releasing (RR) fac- 
March 1983 
Table 1 
Lack of inhibitory effect of bottromycin A2 on the 
puromycin reaction with nascent polypeptides in the 
presence and absence of EFG 
Bottromycin A2 
(1O-4 M) 
EFG, GTP Puromycin 
derivative formed 
(cpm) 
+ - 1412 
+ + - 1486 
+ + 2059 
+ + + 2093 
The experimental conditions are described in the text. 
The values represent he puromycin-dependent decrease 
of radioactive peptide bound to the polysomes. The 
radioactive peptide bound to polysomes was made in 
vitro as described in the text. The ribosome-bound 
radioactivity in the absence of puromycin was 2698 cpm 
Volume 153, number 1 FEBS LETTERS March 1983 
reaction, thus measured, was significantly 
stimulated by EFG, indicating that some of the 
peptidyl-tRNAs were located at the A site while the 
other peptidyl tRNAs were already translocated to 
the D site. It is clear from this table that the EFG- 
dependent puromycin reaction which is an indica- 
tion of the combined reaction of peptide bond for- 
mation and translocation was not influenced by 
bottromycin AZ. 
The fact that the puromycin reaction with 
polysomes was insensitive to bottromycin A2 was 
further supported by the experiment in fig.2. As 
reported earlier, the breakdown of polysomes 
takes place due to the release of ribosomes from 
2s 
2.5 
I I 
20 20 
TUBE NUMBER 
Fig.2. Lack of effect of bottromycin AZ on puromycin- 
dependent polysome breakdown. The experimental 
conditions for polysome breakdown were essentially the 
same as those in [lo]. The reaction mixture (0.25 ml) 
contained 10 mM Tris-HCl (pH 7.4), 8.2 mM MgS04, 
50 mM NHKl, 8.5 mM (NH&Sod, and 6 mM P- 
mercaptoethanol. In addition, it contained 3.2 mM 
phosphoenolpyruvate, 0.16 mM GTP, 16 mg of 
pyruvate kinase, 0.05 mM puromycin, 3.3 4260 nunits 
of polysomes, 98.7 pg of S-150 and the antibiotics where 
indicated. The mixture was incubated at 37°C for 
10 min., cooled to 0°C and layered onto a 5 ml linear 
sucrose gradient (15-30%) in a buffer containing 
10 mM Tris-HCl (pH 7.4), 10 mM Mg-acetate, 50 mM 
NH&l and 6 mM /?-mercaptoethanol. After 
centrifugation at 38000 rev./min for 60 min in a 
Beckman SW50.1 rotor at 4”C, the distribution of the 
ultraviolet-absorbing materials in the gradient was 
monitored with an ISCO gradient analyzer at 254 nm: 
(a) no addition; (b) 10m4 M bottromycin AZ; (c) 10-j M 
sparsomycin; (d) no antibiotic and no incubation. 
Sedimentation was from left to right. The arrows 
represent he position of 70 S ribosomes. 
mRNA in the presence of puromycin, EFG, GTP 
and ribosome-releasing (RR) factor [10,14-161. 
This reaction was dependent on peptide bond for- 
mation between the nascent polypeptide and 
puromycin. It is clear from fig.2 that bottromycin 
A2 did not prevent the loss of polysomes in this 
system. One can conclude from this experiment 
that bottromycin A2 inhibits neither EFG action 
nor peptidyltransferase activity. A control experi- 
ment showed that bottromycin A2 alone did not 
break down polysomes into monosomes in the 
absence of puromycin. As an additional control, a 
peptide synthetase inhibitor, sparsomycin, effec- 
tively inhibited breakdown of the polysomes. 
3.4. Inhibitory effect of bottromycin on the 
binding of aminoacyl-tRNA to poly- 
ribosomes 
The data in section 3.3 eliminate the possibility 
of all but one step in the peptide elongation reac- 
tion being the target of bottromycin AZ; i.e., the 
binding of aminoacyl-tRNA to polysomes. This 
possibility was directly supported by the experi- 
ment indicated in table 2. In this experiment, 
puromycin-treated polysomes were mixed with 
[i4C]aminoacyl-tRNA in the presence of EFTu but 
in the absence of EFG. This table shows that bot- 
tromycin AZ inhibits binding of [14C]aminoacyl- 
tRNA to the polysomes. It should be noted from 
this table that a significant effect of bottromycin 
A2 could be observed after 15 min incubation but 
not after 5 min incubation. A similar effect of bot- 
tromycin was observed with binding of 
phenylalanyl-tRNA to the complex of poly(U) and 
ribosomes [5]. This is consistent with our original 
proposal that bottromycin A2 releases aminoacyl- 
tRNA rather than inhibits the binding itself. 
Table 2 
Effect of bottromycin A2 on the binding of 
[‘4C]aminoacyl-tRNAs to polysomes 
Bottromycin A2 [‘4C]Aminoacyl-tRNA bound 
(1O-4 M) (cpm) 
5 min 15 min 
- 974 1337 
+ 837 524 
The experimental conditions are described in the text 
56 
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3.5. Effect of bottromycin AZ on the run-off of 4. DISCUSSION 
ribosomes from polysomes 
In the experiment shown in fig.3 polysomes were 
isolated from growing E. coli, and protein syn- 
thetic activity as well as sedimentation behavior of 
the polysomes were followed in the presence and 
absence of bottromycin AZ. It is clear from this 
figure that in the absence of antibiotics, protein 
synthesis takes place, accompanied by the disap- 
pearance of the polysomes as a result of run-off of 
ribosomes. When bottromycin AZ, tetracycline, or 
sparsomycin was added, protein synthesis was in- 
hibited. In addition, as a result of inhibition of 
protein synthesis by the antibiotics, more 
polysomes remained intact because fewer 
ribosomes ran off from the polysomes. 
From the preceding work on the effect of bot- 
tromycin AZ on in vitro polypeptide synthesis using 
synthetic polynucleotides, it was postulated that 
bottromycin A2 interferes with the interaction of 
oligo-peptidyl- or aminoacyl-tRNA with the A site 
(acceptor site) of ribosomes [5,6]. This causes 
either release of oligo-peptidyl- and aminoacyl- 
tRNA or inhibition of aa-tRNA binding. We ex- 
tended our study to polysomes and examined 
whether or not the above hypothesis could also be 
applied to the action of bottromycin A2 on 
naturally-occurring polysomes. As in the system 
with synthetic-polynucleotides, bottromycin AZ ex- 
erted a strong inhibitory effect on protein synthesis 
by isolated polysomes. However, polysomes with 
nascent peptides were less sensitive than those 
without. Thus, nascent peptidyl groups attached to 
polysomes appear to retard bottromycin AZ’S ac- 
tion. It should be pointed out that polysomes 
without nascent peptides would ordinarily be very 
unstable in cell extracts because of the presence of 
ribosome-releasing factor [ 10,14- 161. However, 
we have developed a method which eliminates RR 
factor from the extract leaving all other factors for 
protein synthesis [15]. In this RR factor-free ex- 
tract, polysomes without nascent chains are stable. 
We therefore tested the effect of bottromycin A2 
on such polysomes and found that the inhibition of 
protein synthesis was almost complete. 
(a) I (b) -I 
.5- 70s 70s 
-5 
(d) 
TUBE NUMBER 
Fig.3. Bottromycin A2 inhibits run-off of ribosomes 
from polysomes. The experimental conditions for 
protein synthesis by polyribosomes was essentially the 
same as that described in the text. The mixture (0.25 ml) 
contained, in addition to 2.2 A260 nunits of polysomes 
and other components, 210pg tRNA containing 2.1 x 
104 cpm [‘4C]valyl-tRNA and 19 [i2C]aminoacyl tRNAs 
and 435 hg E. coli soluble proteins. After incubating for 
10 min at 37”C, the analysis of polysomal distribution 
was performed as in [lo]. Hot trichloroacetic acid- 
insoluble radioactivity of each fraction was measured by 
the filter disc method: (a) no antibiotic; (b) 10m4 M 
bottromycin AZ; (c) 10m4 M sparsomycin; (d) 5 x 
low4 M tetracycline. Sedimentation was from left to 
right. 
We examined the effect of bottromycin AZ on all 
three steps involved in chain elongation; i.e., bind- 
ing of aminoacyl-tRNA, peptide bond formation, 
and translocation. It was found that, in accord- 
ance with our previous results with systems in- 
volving synthetic polynucleotides, bottromycin A2 
did not inhibit translocation or peptide bond for- 
mation by polyribosomes. On the other hand, the 
aminoacyl-tRNA binding to the polyribosomes 
was inhibited. It should be noted that, in contrast 
to the system using synthetic polynucleotides, bot- 
tromycin A2 did not release bound peptidyl-tRNA 
from polysomes. This is understandable in view of 
the fact that oligopeptidyl- and aminoacyl-tRNA, 
but not polypeptidyl-tRNA, were released from 
complexes of ribosomes and synthetic 
polynucleotides [5]. Bottromycin AZ may not 
release peptidyl-tRNA from polysomes because 
most of the nascent peptides attached to them are 
57 
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relatively large. In fact, large nascent peptidyl- 
tRNA binds tightly to the 50 S ribosomal subunit 
and is not released even at lo-’ M Mg’+ [ 171. 
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From the results of our preceding communica- 
tions and these data we conclude that a similar 
mode of action of bottromycin A2 applies to both 
the polysome system and the synthetic 
polynucleotide system. This antibiotic inhibits pro- 
tein synthesis by interfering with the correct posi- 
tioning of aminoacyl-tRNA in the A-site. This 
would explain the release of aminoacyl-tRNA 
reported here and in [5] since the distorted binding 
of this ligand would probably make it less strongly 
held in the A-site. Since erythromycin releases 
oligopeptidyl-tRNA from ribosomes [8] and 
polysomes [18], the antibiotics are analogous in 
this respect. However, one striking difference is 
that bottromycin A2 releases aminoacyl-tRNA 
from the A site of ribosomes while erythromycin 
releases oligopeptidyl-tRNA from a site near the D 
(donor) (peptidyl) site [19]. In this respect, bot- 
tromycin A2 is similar to tetracycline [20-221 
because both antibiotics act at the A (acceptor) 
site. On the other hand, bottromycin A2 is dif- 
ferent from tetracycline in that it releases bound 
aminoacyl-tRNA, while tetracycline does not [20]. 
Yet another antibiotic, micrococcin, a transloca- 
tion inhibitor [4], is similar to bottromycin A2 in 
that it acts at the A site of ribosomes. However, 
bottromycin A2 differs from micrococcin because 
micrococcin inhibits, like tetracycline, binding of 
aminoacyl-tRNA [9] and does not release 
aminoacyl-tRNA [5] once bound. In addition, bot- 
tromycin A2 does not inhibit translocation while 
micrococcin does [4,9]. These considerations ug- 
gest that an antibiotic which appears to have multi- 
ple effects on various steps of protein synthesis, 
such as bottromycin AZ, erythromycin 
[8,18,23,24], fusidic acid [25-301 or micrococcin 
[9], may actually exert its effects through a single 
action: binding to a particular site of ribosomes. 
Determination of the exact site of the binding of 
these antibiotics by extending already available in- 
formation [31,32] would therefore shed light on 
the mode of ribosome function. 
[I] Tanaka, H., Sashikata, K., Yamaguchi, H. and 
Umezawa, H. (1966) J. Biochem. (Tokyo) 60, 
405-410. 
[2] Lin, Y.C. and Tanaka, N. (1968) J. Biochem. 
(Tokyo) 63, l-7. 
[3] Pestka, S. (1970) Arch. Biochem. Biophys. 136, 
89-96. 
[4] Pestka, S. and Brot, N. (1971) J. Biol. Chem. 246, 
7715-7722. 
[S] Otaka, T. and Kaji, A. (1976) J. Biol. Chem. 251, 
2299-2306. 
[6] Otaka, T. and Kaji, A. (1981) FEBS Lett. 123, 
173-176. 
[7] Pestka, S. (1972) J. Biol. Chem. 247, 4669-4678. 
181 
t91 
DOI 
[Ill 
WI 
P31 
[I41 
WI 
1161 
Otaka, T. and Kaji, A. (1975) Proc. Natl. Acad. 
Sci. USA 72, 2649-2652. 
Otaka, T. and Kaji, A. (1974) Eur. J. Biochem. 50, 
101-106. 
Hirashima, A. and Kaji, A. (1973) J. Biol. Chem. 
248, 7580-7587. 
Mans, R.J. and Novelli, G.D. (1961) Arch. 
Biochem. Biophys. 94, 48-53. 
Weissbach, H., Redfield, B. and Brot, N. (1971) 
Arch. Biochem. Biophys. 145, 676-684. 
Pestka, S. (1974) Antimicrob. Agents Chemother. 
5, 255-267. 
Ryoji, M., Karpen, J.W. and Kaji, A. (1981) J. 
Biol. Chem. 256, 5798-5801. 
Ryoji, M., Berland, R. and Kaji, A. (1981) Proc. 
Natl. Acad. Sci. USA 78, 5973-5977. 
Kung, H., Treadwell, B.V., Spears, C., Tai, P. and 
Weissbach, H. (1977) Proc. Natl. Acad. Sci. USA 
74, 3217-3221. 
1171 
[I81 
[I91 
WI 
ACKNOWLEDGEMENT 
This work was supported by US PHS grant 
GM 12053. 
WI 
PI 
1231 
[241 
1251 
Monro, R. (1969) Nature 223, 903. 
Otaka, T. and Kaji, A. (1982) Arch. Biochem. 
Biophys. 214, 846-849. 
Tanaka, S., Otaka, T. and Kaji, A. (1973) Bio- 
chim. Biophys. Acta 331, 128-140. 
Kaji, A. and Ryoji, M. (1979) Antibiotics VI: 
Mechanism of action of antibacterial agents (Hahn, 
F.E. ed) pp.304-328, Springer Verlag, Berlin, 
Heidelberg. 
Sarkar, S. and Thach, R.E. (1968) Proc. Natl. 
Acad. Sci. USA 60, 1479-1486. 
Suarez, G. and Nathans, D. (1965) Biochem. Bio- 
phys. Res. Commun. 18, 743-750. 
Mao, J.C.H. and Robishaw, E.E. (1972) 
Biochemistry 11, 4864-4872. 
Tanaka, K. and Teraoka, H. (1968) J. Biochem. 
(Tokyo) 64, 635-648. 
Otaka, T. and Kaji, A. (1973) Eur. J. Biochem. 38, 
46-53. 
58 
March 1983 
Volume 153, number 1 FEBS LETTERS March 1983 
[26] Richman, N. and Bodley, J.W. (1971) Proc. Natl. 
Acad. Sci. USA 69, 686-689. 
[27] Cabrer, B., Vazquez, D. and Modolell, J. (1972) 
Proc. Natl. Acad. Sci. USA 69, 733-736. 
[28] Miller, D.L. (1972) Proc. Natl. Acad. Sci. USA 69, 
752-755. 
[29] Richter, D. (1972) Biochem. Biophys. Res. Com- 
mun. 46, 1850-1856. 
[30] Modolell, J. and Vazquez, D. (1973) J. Biol. Chem. 
248, 488-493. 
[31] Langlois, R., Lee, CC., Cantor, C.R., Vince, R. 
and Pestka, S. (1976) J. Mol. Biol. 106, 297-313. 
[32] Langlois, R., Cantor, C.R., Vince, R. and Pestka, 
S. (1977) Biochemistry 16, 2349-2356. 
59 
